Abstract
Ischemic stroke is a common neurological disease and a leading cause of permanent disability in many countries. Recent studies provide evidence on the role of the suppressor of the cytokine signaling 1 (SOCS1) gene in the development and progression of atherosclerotic lesions. However, few studies have assessed the association between single nucleotide polymorphisms (SNPs) on SOCS1 gene and ischemic stroke. Therefore, the present study aimed to investigate the role of SOCS1 polymorphism in ischemic stroke risk in a northern Chinese Han population. We examined 475 patients with ischemic stroke and 486 normal controls. Three SNPs (rs243327, rs243330, and rs33932899) of SOCS1 gene were determined for TaqMan genotyping assays. We also classified these case samples in depth by complications with hypertension or diabetes and by ischemic stroke subtypes. When adjusting models by multiple factor analysis by logistic regression, then calculated 10,000 permutations were performed for each model to correct the multiple test. Under additive model, the rs243327 was associated with ischemic stroke with hypertension (p = 0.047). Under heterozygous model, the rs33932899 and rs243330 were significantly associated with ischemic stroke subtypes by atherosclerosis (p = 0.038, p = 0.048, respectively). In summary, our data demonstrated for the first time that the polymorphisms of the SOCS1 gene are associated with the risk of ischemic stroke in a northern Chinese Han population, suggesting that SOCS1 gene polymorphisms may play an important role in the pathogenesis of ischemic stroke.
Similar content being viewed by others
References
Adams, H. P, Jr, Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., et al. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24(1), 35–41.
Bak, S., Gaist, D., Sindrup, S. H., Skytthe, A., & Christensen, K. (2002). Genetic liability in stroke: A long-term follow-up study of Danish twins. Stroke, 33(3), 769–774.
Brass, L. M., Isaacsohn, J. L., Merikangas, K. R., & Robinette, C. D. (1992). A study of twins and stroke. Stroke, 23(2), 221–223.
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., et al. (1997). A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387(6636), 921–924. doi:10.1038/43213.
Fan, Y., Chen, H., Li, A., Shi, Y., Zhang, Y., Feng, Q., et al. (2015). A promoter polymorphism (rs17222919, -1316T/G) of ALOX5AP gene is associated with decreased risk of ischemic stroke in two independent Chinese populations. PLoS One, 10(3), e0122393. doi:10.1371/journal.pone.0122393.
Gylvin, T., Ek, J., Nolsoe, R., Albrechtsen, A., Andersen, G., Bergholdt, R., et al. (2009). Functional SOCS1 polymorphisms are associated with variation in obesity in whites. Diabetes, Obesity and Metabolism, 11(3), 196–203. doi:10.1111/j.1463-1326.2008.00900.x.
Harada, M., Nakashima, K., Hirota, T., Shimizu, M., Doi, S., Fujita, K., et al. (2007). Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. American Journal of Respiratory Cell and Molecular Biology, 36(4), 491–496. doi:10.1165/rcmb.2006-0090OC.
Hashimoto, M., Ayada, T., Kinjyo, I., Hiwatashi, K., Yoshida, H., Okada, Y., et al. (2009). Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation. Cancer Science, 100(4), 730–736.
Hirschfield, G. M., Xie, G., Lu, E., Sun, Y., Juran, B. D., Chellappa, V., et al. (2012). Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes and Immunity, 13(4), 328–335. doi:10.1038/gene.2011.89.
Huang, K., Tang, W., Tang, R., Xu, Z., He, Z., Li, Z., et al. (2008). Positive association between OLIG2 and schizophrenia in the Chinese Han population. Human Genetics, 122(6), 659–660. doi:10.1007/s00439-007-0434-z.
Jin, R., Yang, G., & Li, G. (2010). Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. Journal of Leukocyte Biology, 87(5), 779–789. doi:10.1189/jlb.1109766.
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006). Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet, 367(9524), 1747–1757. doi:10.1016/S0140-6736(06)68770-9.
Lovkvist, H., Olsson, S., Hoglund, P., Melander, O., Jern, C., Sjogren, M., et al. (2012). A large-sample assessment of possible association between ischaemic stroke and rs12188950 in the PDE4D gene. European Journal of Human Genetics, 20(7), 783–789. doi:10.1038/ejhg.2012.4.
Macrez, R., Ali, C., Toutirais, O., Le Mauff, B., Defer, G., Dirnagl, U., et al. (2011). Stroke and the immune system: From pathophysiology to new therapeutic strategies. Lancet Neurology, 10(5), 471–480. doi:10.1016/S1474-4422(11)70066-7.
Matsuda, T., Yamamoto, T., Kishi, H., Yoshimura, A., & Muraguchi, A. (2000). SOCS-1 can suppress CD3ζ-and Syk-mediated NF-AT activation in a non-lymphoid cell line. FEBS Letters, 472(2–3), 235–240.
Mooney, R. A., Senn, J., Cameron, S., Inamdar, N., Boivin, L. M., Shang, Y., et al. (2001). Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor: A potential mechanism for cytokine-mediated insulin resistance. Journal of Biological Chemistry, 276(28), 25889–25893. doi:10.1074/jbc.M010579200.
Morganti-Kossman, M. C., Lenzlinger, P. M., Hans, V., Stahel, P., Csuka, E., Ammann, E., et al. (1997). Production of cytokines following brain injury: Beneficial and deleterious for the damaged tissue. Molecular Psychiatry, 2(2), 133–136.
Mostecki, J., Cassel, S. L., Klimecki, W. T., Stern, D. A., Knisz, J., Iwashita, S., et al. (2011). A SOCS-1 promoter variant is associated with total serum IgE levels. Journal of Immunology, 187(5), 2794–2802. doi:10.4049/jimmunol.0902569.
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., et al. (1997). Structure and function of a new STAT-induced STAT inhibitor. Nature, 387(6636), 924–929. doi:10.1038/43219.
Ortiz-Munoz, G., Martin-Ventura, J. L., Hernandez-Vargas, P., Mallavia, B., Lopez-Parra, V., Lopez-Franco, O., et al. (2009). Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(4), 525–531. doi:10.1161/ATVBAHA.108.173781.
Palmer, D. C., & Restifo, N. P. (2009). Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends in Immunology, 30(12), 592–602. doi:10.1016/j.it.2009.09.009.
Recio, C., Oguiza, A., Mallavia, B., Lazaro, I., Ortiz-Munoz, G., Lopez-Franco, O., et al. (2015). Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice. Basic Research in Cardiology, 110(2), 8. doi:10.1007/s00395-014-0458-1.
Ross, R. (1999). Atherosclerosis—An inflammatory disease. New England Journal of Medicine, 340(2), 115–126. doi:10.1056/NEJM199901143400207.
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., et al. (1997). A family of cytokine-inducible inhibitors of signalling. Nature, 387(6636), 917–921. doi:10.1038/43206.
Tamiya, T., Kashiwagi, I., Takahashi, R., Yasukawa, H., & Yoshimura, A. (2011). Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: Regulation of T-cell inflammation by SOCS1 and SOCS3. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 980–985. doi:10.1161/ATVBAHA.110.207464.
Vargas-Alarcon, G., Posadas-Sanchez, R., Posadas-Romero, C., Gonzalez-Salazar, C., Cardoso-Saldana, G., Martinez-Rios, M. A., et al. (2014). Association of the suppressor of cytokine signaling 1 (SOCS1) gene polymorphisms with acute coronary syndrome in Mexican patients. Molecular Immunology, 62(1), 137–141. doi:10.1016/j.molimm.2014.06.019.
Zhang, J. G., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., et al. (2015). Correction for Zhang et al., The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proceedings of the National Academy of Sciences USA, 112(22), E2979. doi:10.1073/pnas.1507812112.
Zhang, R., Li, X., Liu, N., Guo, X., Liu, W., Ning, C., et al. (2013). An association study on renalase polymorphisms and ischemic stroke in a Chinese population. Neuromolecular Medicine, 15(2), 396–404. doi:10.1007/s12017-013-8227-0.
Zhao, J., He, Z., Ma, S., & Li, L. (2012). Association of ALOX15 gene polymorphism with ischemic stroke in Northern Chinese Han population. Journal of Molecular Neuroscience, 47(3), 458–464. doi:10.1007/s12031-012-9721-9.
Acknowledgments
This work was supported by the Natural Science Foundation of Heilongjiang province (No. H201331).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no conflict of interest.
Additional information
Qi Ma and Nana Liu: Co first authors.
Rights and permissions
About this article
Cite this article
Ma, Q., Liu, N., Zhang, R. et al. A Novel Association of the Suppressor of Cytokine Signaling 1 (SOCS1) Gene Polymorphisms in Ischemic Stroke Patients. Neuromol Med 18, 573–580 (2016). https://doi.org/10.1007/s12017-016-8406-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-016-8406-x